Ascletis Pharma, Gannex Pharma Face ITC Exclusion, Cease & Desist Orders Over Trade Secret Misappropriation
June 06, 2025
June 06, 2025
WASHINGTON, June 6 (TNSFR) -- The International Trade Commission has issued a final determination finding a violation of Section 337 of the Tariff Act of 1930 as amended in an investigation concerning certain selective thyroid hormone receptor-beta agonists. This ruling specifically targets companies for misappropriation of trade secrets, leading to the issuance of a limited exclusion order and cease and desist orders.
The Commission's investigation, initiated on February 9, 20 . . .
The Commission's investigation, initiated on February 9, 20 . . .